{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:44:44Z","timestamp":1790844284802,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1038\/s41375-020-01063-7","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T13:05:59Z","timestamp":1603285559000},"page":"1610-1620","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["CXCL13 plasma levels function as a biomarker for disease activity in patients with chronic lymphocytic leukemia"],"prefix":"10.1038","volume":"35","author":[{"given":"Mariela","family":"Sivina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianchun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Vaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Shih","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Keating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Ferrajoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeev","family":"Estrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Wierda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Chiorazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6177-7572","authenticated-orcid":false,"given":"Jan A.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,21]]},"reference":[{"key":"1063_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nrc.2017.121","volume":"18","author":"JA Burger","year":"2018","unstructured":"Burger JA, Wiestner A. Targeting B cell receptor signalling in cancer: preclinical and clinical advances. Nat Rev. 2018;18:148\u201367.","journal-title":"Nat Rev"},{"key":"1063_CR2","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1177\/28.8.7003001","volume":"28","author":"H Stein","year":"1980","unstructured":"Stein H, Bonk A, Tolksdorf G, Lennert K, Rodt H, Gerdes J. Immunohistologic analysis of the organization of normal lymphoid tissue and non-Hodgkin\u2019s lymphomas. J Histochem Cytochem. 1980;28:746\u201360.","journal-title":"J Histochem Cytochem"},{"key":"1063_CR3","doi-asserted-by":"publisher","first-page":"5173","DOI":"10.1182\/blood-2007-08-108605","volume":"111","author":"PE Patten","year":"2008","unstructured":"Patten PE, Buggins AG, Richards J, Wotherspoon A, Salisbury J, Mufti GJ, et al. CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment. Blood. 2008;111:5173\u201381.","journal-title":"Blood"},{"key":"1063_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1182\/blood-2010-05-284984","volume":"117","author":"Y Herishanu","year":"2011","unstructured":"Herishanu Y, Perez-Galan P, Liu D, Biancotto A, Pittaluga S, Vire B, et al. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood. 2011;117:563\u201374.","journal-title":"Blood"},{"key":"1063_CR5","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.immuni.2006.10.011","volume":"25","author":"M Bajenoff","year":"2006","unstructured":"Bajenoff M, Egen JG, Koo LY, Laugier JP, Brau F, Glaichenhaus N, et al. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity. 2006;25:989\u20131001.","journal-title":"Immunity"},{"key":"1063_CR6","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/ni1100","volume":"5","author":"CD Allen","year":"2004","unstructured":"Allen CD, Ansel KM, Low C, Lesley R, Tamamura H, Fujii N, et al. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat Immunol. 2004;5:943\u201352.","journal-title":"Nat Immunol"},{"key":"1063_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nature05573","volume":"446","author":"TA Schwickert","year":"2007","unstructured":"Schwickert TA, Lindquist RL, Shakhar G, Livshits G, Skokos D, Kosco-Vilbois MH, et al. In vivo imaging of germinal centres reveals a dynamic open structure. Nature. 2007;446:83\u20137.","journal-title":"Nature"},{"key":"1063_CR8","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1126\/science.1136736","volume":"315","author":"CD Allen","year":"2007","unstructured":"Allen CD, Okada T, Tang HL, Cyster JG. Imaging of germinal center selection events during affinity maturation. Science. 2007;315:528\u201331.","journal-title":"Science"},{"key":"1063_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/35018581","volume":"406","author":"KM Ansel","year":"2000","unstructured":"Ansel KM, Ngo VN, Hyman PL, Luther SA, Forster R, Sedgwick JD, et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature. 2000;406:309\u201314.","journal-title":"Nature"},{"key":"1063_CR10","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1146\/annurev-immunol-020711-075032","volume":"30","author":"GD Victora","year":"2012","unstructured":"Victora GD, Nussenzweig MC. Germinal centers. Annu Rev Immunol. 2012;30:429\u201357.","journal-title":"Annu Rev Immunol"},{"key":"1063_CR11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/ni1542","volume":"9","author":"G Cinamon","year":"2008","unstructured":"Cinamon G, Zachariah MA, Lam OM, Foss FW Jr, Cyster JG. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat Immunol. 2008;9:54\u201362.","journal-title":"Nat Immunol"},{"key":"1063_CR12","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/nri2588","volume":"9","author":"SN Mueller","year":"2009","unstructured":"Mueller SN, Germain RN. Stromal cell contributions to the homeostasis and functionality of the immune system. Nat Rev Immunol. 2009;9:618\u201329.","journal-title":"Nat Rev Immunol"},{"key":"1063_CR13","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1182\/blood-2011-01-332106","volume":"118","author":"J Saez de Guinoa","year":"2011","unstructured":"Saez de Guinoa J, Barrio L, Mellado M, Carrasco YR. CXCL13\/CXCR5 signaling enhances BCR-triggered B-cell activation by shaping cell dynamics. Blood. 2011;118:1560\u20139.","journal-title":"Blood"},{"key":"1063_CR14","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1073\/pnas.1520112113","volume":"113","author":"C Havenar-Daughton","year":"2016","unstructured":"Havenar-Daughton C, Lindqvist M, Heit A, Wu JE, Reiss SM, Kendric K, et al. CXCL13 is a plasma biomarker of germinal center activity. Proc Natl Acad Sci USA. 2016;113:2702\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1063_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3389\/fimmu.2019.00289","volume":"10","author":"V Mehraj","year":"2019","unstructured":"Mehraj V, Ramendra R, Isnard S, Dupuy FP, Lebouche B, Costiniuk C, et al. CXCL13 as a biomarker of immune activation during early and chronic HIV infection. Front Immunol. 2019;10:289.","journal-title":"Front Immunol"},{"key":"1063_CR16","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1182\/blood-2007-05-089409","volume":"110","author":"A Burkle","year":"2007","unstructured":"Burkle A, Niedermeier M, Schmitt-Graff A, Wierda WG, Keating MJ, Burger JA. Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. Blood. 2007;110:3316\u201325.","journal-title":"Blood"},{"key":"1063_CR17","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/sj.leu.2402107","volume":"15","author":"J Durig","year":"2001","unstructured":"Durig J, Schmucker U, Duhrsen U. Differential expression of chemokine receptors in B cell malignancies. Leukemia. 2001;15:752\u20136.","journal-title":"Leukemia"},{"key":"1063_CR18","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1189\/jlb.1203652","volume":"76","author":"S Lopez-Giral","year":"2004","unstructured":"Lopez-Giral S, Quintana NE, Cabrerizo M, Alfonso-Perez M, Sala-Valdes M, De Soria VG, et al. Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination. J Leukoc Biol. 2004;76:462\u201371.","journal-title":"J Leukoc Biol"},{"key":"1063_CR19","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1182\/blood-2003-09-3103","volume":"104","author":"L Trentin","year":"2004","unstructured":"Trentin L, Cabrelle A, Facco M, Carollo D, Miorin M, Tosoni A, et al. Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas. Blood. 2004;104:502\u20138.","journal-title":"Blood"},{"key":"1063_CR20","doi-asserted-by":"publisher","first-page":"e1323155","DOI":"10.1080\/2162402X.2017.1323155","volume":"6","author":"V Stache","year":"2017","unstructured":"Stache V, Verlaat L, Gatjen M, Heinig K, Westermann J, Rehm A, et al. The splenic marginal zone shapes the phenotype of leukemia B cells and facilitates their niche-specific retention and survival. Oncoimmunology. 2017;6:e1323155.","journal-title":"Oncoimmunology"},{"key":"1063_CR21","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1182\/blood-2008-07-170415","volume":"113","author":"JA Burger","year":"2009","unstructured":"Burger JA, Quiroga MP, Hartmann E, Burkle A, Wierda WG, Keating MJ, et al. High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation. Blood. 2009;113:3050\u20138.","journal-title":"Blood"},{"key":"1063_CR22","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3109\/10428194.2015.1068308","volume":"57","author":"EM Hartmann","year":"2016","unstructured":"Hartmann EM, Rudelius M, Burger JA, Rosenwald A. CCL3 chemokine expression by chronic lymphocytic leukemia cells orchestrates the composition of the microenvironment in lymph node infiltrates. Leuk Lymphoma. 2016;57:563\u201371.","journal-title":"Leuk Lymphoma"},{"key":"1063_CR23","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.3389\/fimmu.2018.02044","volume":"9","author":"ZL Benet","year":"2018","unstructured":"Benet ZL, Marthi M, Ke F, Wu R, Turner JS, Gabayre JB, et al. CCL3 promotes germinal center B cells sampling by follicular regulatory T cells in murine lymph nodes. Front Immunol. 2018;9:2044.","journal-title":"Front Immunol"},{"key":"1063_CR24","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","volume":"111","author":"M Hallek","year":"2008","unstructured":"Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008;111:5446\u201356.","journal-title":"Blood"},{"key":"1063_CR25","doi-asserted-by":"publisher","first-page":"e89904","DOI":"10.1172\/jci.insight.89904","volume":"2","author":"JA Burger","year":"2017","unstructured":"Burger JA, Li KW, Keating MJ, Sivina M, Amer AM, Garg N, et al. Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinib. JCI insight. 2017;2:e89904.","journal-title":"JCI insight"},{"key":"1063_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S1074-7613(00)80199-5","volume":"12","author":"SA Luther","year":"2000","unstructured":"Luther SA, Lopez T, Bai W, Hanahan D, Cyster JG. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity. 2000;12:471\u201381.","journal-title":"Immunity"},{"key":"1063_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3899\/jrheum.090450","volume":"37","author":"HT Lee","year":"2010","unstructured":"Lee HT, Shiao YM, Wu TH, Chen WS, Hsu YH, Tsai SF, et al. Serum BLC\/CXCL13 concentrations and renal expression of CXCL13\/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis. J Rheumatol. 2010;37:45\u201352.","journal-title":"J Rheumatol"},{"key":"1063_CR28","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/eci.12063","volume":"43","author":"DK Finch","year":"2013","unstructured":"Finch DK, Ettinger R, Karnell JL, Herbst R, Sleeman MA. Effects of CXCL13 inhibition on lymphoid follicles in models of autoimmune disease. Eur J Clin Investig. 2013;43:501\u20139.","journal-title":"Eur J Clin Investig"},{"key":"1063_CR29","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/leu.2017.11","volume":"31","author":"TM Herndon","year":"2017","unstructured":"Herndon TM, Chen SS, Saba NS, Valdez J, Emson C, Gatmaitan M, et al. Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood. Leukemia. 2017;31:1340\u20137.","journal-title":"Leukemia"},{"key":"1063_CR30","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1158\/1078-0432.CCR-15-1965","volume":"22","author":"CU Niemann","year":"2016","unstructured":"Niemann CU, Herman SE, Maric I, Gomez-Rodriguez J, Biancotto A, Chang BY, et al. Disruption of in vivo chronic lymphocytic leukemia tumor-microenvironment interactions by ibrutinib-findings from an investigator-initiated phase II study. Clin Cancer Res. 2016;22:1572\u201382.","journal-title":"Clin Cancer Res"},{"key":"1063_CR31","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1182\/blood-2016-06-719294","volume":"129","author":"IE Ahn","year":"2017","unstructured":"Ahn IE, Underbayev C, Albitar A, Herman SE, Tian X, Maric I, et al. Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia. Blood. 2017;129:1469\u201379.","journal-title":"Blood"},{"key":"1063_CR32","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1158\/2159-8290.CD-14-0096","volume":"4","author":"K Heinig","year":"2014","unstructured":"Heinig K, Gatjen M, Grau M, Stache V, Anagnostopoulos I, Gerlach K, et al. Access to follicular dendritic cells is a pivotal step in murine chronic lymphocytic leukemia B-cell activation and proliferation. Cancer Discov. 2014;4:1448\u201365.","journal-title":"Cancer Discov"},{"key":"1063_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04150-7","volume":"9","author":"D Farinello","year":"2018","unstructured":"Farinello D, Wozinska M, Lenti E, Genovese L, Bianchessi S, Migliori E, et al. A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progression. Nat Commun. 2018;9:1787.","journal-title":"Nat Commun"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-020-01063-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-020-01063-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-020-01063-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T23:19:44Z","timestamp":1634771984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-020-01063-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,21]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["1063"],"URL":"https:\/\/doi.org\/10.1038\/s41375-020-01063-7","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,21]]},"assertion":[{"value":"31 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"JAB, NJ, and WGW received research funding from Pharmacyclics, an AbbVie company. The remaining authors declared no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}